Summit Life Sciences
CBD Infused formulation in joint venture production/distribution.
THUNDERgro® water treatment products to increase plant yield and quality. http://www.thundergro.com
GenBio Inc is a start-up, pre-clinical USA based Biotechnology Company pioneering a comprehensive drug development program into novel small molecules specifically for anti-inflammatory conditions.
Our vision is to bring to market an entirely new class of anti-inflammatory drugs for the treatment of arthritis.
The Company’s research program leverages its in-depth knowledge and past research into the phytochemistry and bioactivity of an extract demonstrating outstanding medical properties.
Our research indicates never seen before bioactivity and phytochemistry of both the identified molecules and compounds which has the potential to be translated into a new range of drugs which will overcome many of the limitations inherent in existing drug treatments and modalities.
The Company believes it has discovered one of the great discoveries of the 21 Century.
The Company’s commercial strategy is to employ its proprietary drug discovery platform to generate novel therapeutic agents for use in distinct anti-inflammatory markets.
Our research program is carried out by specialist scientific teams in the USA and Canada, building off many years of ground-breaking academic research which has been conducted in secrecy worldwide.
The Company’s lead molecule has been demonstrated to inhibit several complementary pathways, enabling more potent and yet less toxic therapeutic intervention. Successful ring-fencing and protection of the ensuing Intellectual Property (IP) should help create an exclusive monopoly for the Company on an entire new class of highly valuable pharmaceutical, natural health and nutraceutical products and address an unmet need in the global marketplace.
Our drug program will advance the candidate through all FDA mandated dosage, efficacy and toxicology studies to Investigational New Drug (IND) application phase within 36-48 months.
Fund management intends to acquire 100+ acres along the Yamhill River in beautiful McMinnville, OR, including a golf course with clubhouse with commercial kitchen, and adjacent property. We intend to improve the property and provide free public access to this local landmark and links, which will showcase the healing properties of botanical medicines derived from common and exotic plants that have been proven effective in treating chronic ailments for millennia. To further enhance the well-being of the community, local charitable organizations will be welcome to host fundraisers and tournaments as well.
Solving some of our community’s and country’s most painful problems begins with healing our most vulnerable neighbors such as disabled veterans, the elderly, and those suffering from addiction, neurological disorders, cancer, and chronic pain. By engaging the brightest minds in holistic healing and hosting open-to-the-public seminars, symposiums, and educational programs we hope to make a positive impact on our community for generations to come.
American Bio Technologies, Inc.
An agriculture solutions and technology firm serving the nutraceutical, food processing and cannabis & hemp industries.
One of the largest internationally accredited testing labs in America, this 10,500 square foot laboratory is strategically located in Salinas, CA.
State-mandated testing is the bottleneck in the cannabis and hemp industry, with excessive supply.
EBITDA positive before end of 2021.
Initial capital will fund additional testing equipment to meet demand and scale revenues over $20mm by 2021.
Plans to expand locations and apply technologies to broader industries of vertical farming and greenhouse growing.